Scheme for Strengthening of Pharmaceutical Industry
On 11th March, 2022, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, released the guidelines for the scheme “Strengthening of Pharmaceutical Industry (SPI)".
Aim
- To strengthen the existing infrastructure facilities in the Pharma Sector.
Salient Features
- Under the Scheme, financial assistance to pharma clusters will be provided for creation of Common Facilities. This will not only improve the quality but also ensure the sustainable growth of clusters.
- Further, in order to upgrade the production facilities of SMEs and MSMEs so as to meet national and international regulatory standards (WHO-GMP or Schedule-M), interest subvention or capital subsidy on their capital loans will ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Annual Survey of Services Sector Enterprises
- 2 Paste Fill Technology for Coal Mining
- 3 Multi Modal Logistics Park
- 4 Vizhinjam Seaport: India's First Deep-Water Container Transshipment Port
- 5 SEBI's Proposed Ease of Doing Business Measures for REITs and INVITs
- 6 Common Contract Note
- 7 Standing Deposit Facility
- 8 Green Municipal Bonds
- 9 M-CADWM Scheme Approved
- 10 Guidelines for Setting up Bio-Input Resource Centres

- 1 Supreme Court Panel Report on Repealed Farm Laws
- 2 Carbon-Neutral Agriculture
- 3 Rupee-Rouble Trade Agreement
- 4 RBI Removes Pricing Caps for Microfinance Lenders
- 5 Framework for Geo-tagging of Payment System Touch Points
- 6 National Land Monetisation Corporation
- 7 Brahmaputra (NW2) gets connected with Ganga (NW1)
- 8 Virtual Smart Grid Knowledge Centre
- 9 Raising and Accelerating MSME Performance
- 10 Coastal Economic Zone
- 11 National Pharmaceutical Pricing Authority